{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T20:07:51Z","timestamp":1784664471841,"version":"3.55.0"},"reference-count":40,"publisher":"Informa UK Limited","issue":"16","license":[{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"funder":[{"DOI":"10.13039\/501100022274","name":"Daiichi Sankyo","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100022274","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Future Oncology"],"published-print":{"date-parts":[[2026,7,3]]},"DOI":"10.1080\/14796694.2026.2689464","type":"journal-article","created":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T10:25:42Z","timestamp":1783765542000},"page":"1913-1924","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["QuANTUM-Wild: a Phase III, randomized trial of quizartinib in newly diagnosed\n                    <i>FLT3<\/i>\n                    -ITD\u2013negative acute myeloid leukemia"],"prefix":"10.1080","volume":"22","author":[{"given":"Pau","family":"Montesinos","sequence":"first","affiliation":[{"name":"Hospital Universitari I Polit\u00e9cnic La Fe and Programa Espa\u00f1ol de Tratamientos en Hematolog\u00eda (PETHEMA) Group","place":["Valencia, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica K.","family":"Altman","sequence":"additional","affiliation":[{"name":"Robert H. Lurie Comprehensive Cancer Center of Northwestern University","place":["Chicago, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Bullinger","sequence":"additional","affiliation":[{"name":"Charit\u00e9 - Universit\u00e4tsmedizin Berlin, Corporate member of Freie Universit\u00e4t and Humboldt-Universit\u00e4t zu Berlin","place":["Berlin, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"June-Won","family":"Cheong","sequence":"additional","affiliation":[{"name":"Yonsei University College of Medicine","place":["Seoul, Republic of Korea (South)"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir T.","family":"Fathi","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital Cancer Center","place":["Boston, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J.","family":"Levis","sequence":"additional","affiliation":[{"name":"Johns Hopkins University","place":["Baltimore, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selina","family":"Luger","sequence":"additional","affiliation":[{"name":"University of Pennsylvania","place":["Philadelphia, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiro","family":"Miyamoto","sequence":"additional","affiliation":[{"name":"Kanazawa University","place":["Kanazawa, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther Natalie","family":"Oliva","sequence":"additional","affiliation":[{"name":"London North West University Healthcare NHS Trust","place":["London, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander E.","family":"Perl","sequence":"additional","affiliation":[{"name":"University of Pennsylvania","place":["Philadelphia, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"R\u00e9cher","sequence":"additional","affiliation":[{"name":"Service d\u2019h\u00e9matologie","place":["Toulouse, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebeca Rodriquez","family":"Veiga","sequence":"additional","affiliation":[{"name":"Hospital Universitari I Polit\u00e9cnic La Fe and Programa Espa\u00f1ol de Tratamientos en Hematolog\u00eda (PETHEMA) Group","place":["Valencia, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxiang","family":"Wang","sequence":"additional","affiliation":[{"name":"Chinese Academy of Medical Sciences and Peking Union Medical College","place":["Tianjin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amer M.","family":"Zeidan","sequence":"additional","affiliation":[{"name":"Yale School of Medicine","place":["New Haven, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Liu","sequence":"additional","affiliation":[{"name":"Daiichi Sankyo Inc","place":["Basking Ridge, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Duong","sequence":"additional","affiliation":[{"name":"Daiichi Sankyo Inc","place":["Basking Ridge, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime E. Connolly","family":"Rohrbach","sequence":"additional","affiliation":[{"name":"Daiichi Sankyo Inc","place":["Basking Ridge, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Inghirami","sequence":"additional","affiliation":[{"name":"Daiichi Sankyo Inc","place":["Basking Ridge, USA"]},{"name":"Weill Cornell Medicine","place":["New York, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karenza","family":"Alexis","sequence":"additional","affiliation":[{"name":"Daiichi Sankyo Inc","place":["Basking Ridge, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Gosberg","sequence":"additional","affiliation":[{"name":"Daiichi Sankyo Inc","place":["Basking Ridge, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akash","family":"Nahar","sequence":"additional","affiliation":[{"name":"Daiichi Sankyo Inc","place":["Basking Ridge, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristy","family":"Burns","sequence":"additional","affiliation":[{"name":"Daiichi Sankyo Inc","place":["Basking Ridge, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naval","family":"Daver","sequence":"additional","affiliation":[{"name":"The University of Texas MD Anderson Cancer Center","place":["Houston, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry P.","family":"Erba","sequence":"additional","affiliation":[{"name":"Duke University Cancer Institute","place":["Durham, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,7,11]]},"reference":[{"key":"e_1_3_7_3_1","doi-asserted-by":"publisher","DOI":"10.3389\/ebm.2025.10235"},{"key":"e_1_3_7_4_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1406184"},{"key":"e_1_3_7_5_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.612880"},{"key":"e_1_3_7_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2016.50"},{"key":"e_1_3_7_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.15032"},{"key":"e_1_3_7_8_1","unstructured":"Referenced with permission from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae) for acute myeloid leukemia V.3.2026. \u00a9 National Comprehensive Cancer Network Inc. 2026. All rights reserved. Accessed January 25 2026. To view the most recent and complete version of the guideline go online to NCCN.org. NCCN makes no warranties of any kind whatsoever regarding their content use or application and disclaims any responsibility for their application or use in any way."},{"key":"e_1_3_7_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.117788"},{"key":"e_1_3_7_10_1","doi-asserted-by":"publisher","DOI":"10.1186\/1756-8722-4-13"},{"key":"e_1_3_7_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/cas.14274"},{"key":"e_1_3_7_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-018-0357-9"},{"key":"e_1_3_7_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402622"},{"key":"e_1_3_7_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401130"},{"key":"e_1_3_7_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30240-7"},{"key":"e_1_3_7_16_1","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2017.8232"},{"key":"e_1_3_7_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-023-03681-0"},{"key":"e_1_3_7_18_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.27489"},{"key":"e_1_3_7_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)00464-6"},{"key":"e_1_3_7_20_1","unstructured":"Food and Drug Administration. Vanflyta (quizartinib) prescribing information. 2023 [cited 2025 Jan 22]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2023\/216993s000lbl.pdf"},{"key":"e_1_3_7_21_1","unstructured":"European Medicines Agency. Vanflyta (quizartinib) product information. 2023 [cited 2025 Jan 22]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/vanflyta-epar-product-information_en.pdf"},{"key":"e_1_3_7_22_1","unstructured":"Medicines and Healthcare Products Regulatory Agency. Vanflyta (quizartinib) package leaflet. 2024 [cited 2025 Jan 22]. Available from: https:\/\/mhraproducts4853.blob.core.windows.net\/docs\/0326f7004d028580913d338d85653c60ee967d20"},{"key":"e_1_3_7_23_1","unstructured":"Sankyo D. VANFLYTA\u00ae first FLT3 inhibitor approved in Japan for patients with newly diagnosed FLT3-ITD positive AML [Internet]. 2023 [cited 2025 Jan 22]. Available from: https:\/\/www.daiichisankyo.com\/files\/news\/pressrelease\/pdf\/202305\/20230525_E.pdf"},{"key":"e_1_3_7_24_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V87.3.1089.bloodjournal8731089"},{"issue":"2","key":"e_1_3_7_25_1","first-page":"238","article-title":"Human FLT3\/FLK2 receptor tyrosine kinase is expressed at the surface of normal and malignant hematopoietic cells","volume":"10","author":"Rosenet O","year":"1996","unstructured":"Rosenet O, B\u00fchring HJ, Marchetto S, et al. Human FLT3\/FLK2 receptor tyrosine kinase is expressed at the surface of normal and malignant hematopoietic cells. Leukemia. 1996;10(2):238\u2013248.","journal-title":"Leukemia"},{"key":"e_1_3_7_26_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-07-2441"},{"key":"e_1_3_7_27_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-04-261867"},{"key":"e_1_3_7_28_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-09-115055"},{"issue":"5","key":"e_1_3_7_29_1","first-page":"885","article-title":"Expression of the FLT3 gene in human leukemia-lymphoma cell lines","volume":"8","author":"DaSilva N","year":"1994","unstructured":"DaSilva N, Hu ZB, Ma W, et al. Expression of the FLT3 gene in human leukemia-lymphoma cell lines. Leukemia. 1994;8(5):885\u2013888.","journal-title":"Leukemia"},{"issue":"8","key":"e_1_3_7_30_1","first-page":"1368","article-title":"Expression of FLT3 receptor and FLT3-ligand in human leukemia-lymphoma cell lines","volume":"9","author":"Meierhoff G","year":"1995","unstructured":"Meierhoff G, Dehmel U, Gruss HJ, et al. Expression of FLT3 receptor and FLT3-ligand in human leukemia-lymphoma cell lines. Leukemia. 1995;9(8):1368\u20131372.","journal-title":"Leukemia"},{"issue":"4","key":"e_1_3_7_31_1","first-page":"588","article-title":"Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells","volume":"10","author":"Drexler HG","year":"1996","unstructured":"Drexler HG. Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells. Leukemia. 1996;10(4):588\u2013599.","journal-title":"Leukemia"},{"key":"e_1_3_7_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11899-010-0049-7"},{"key":"e_1_3_7_33_1","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2024.13353"},{"key":"e_1_3_7_34_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-05-222034"},{"key":"e_1_3_7_35_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.48.8783"},{"key":"e_1_3_7_36_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO-25-01841"},{"key":"e_1_3_7_37_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-180482"},{"key":"e_1_3_7_38_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022016867"},{"key":"e_1_3_7_39_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.04.036"},{"key":"e_1_3_7_40_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2025017738"},{"key":"e_1_3_7_41_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-021-01148-x"},{"key":"e_1_3_7_42_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2021-148129"}],"container-title":["Future Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14796694.2026.2689464","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/14796694.2026.2689464","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14796694.2026.2689464","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T19:47:01Z","timestamp":1784663221000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14796694.2026.2689464"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,3]]},"references-count":40,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2026,7,3]]}},"alternative-id":["10.1080\/14796694.2026.2689464"],"URL":"https:\/\/doi.org\/10.1080\/14796694.2026.2689464","relation":{},"ISSN":["1479-6694","1744-8301"],"issn-type":[{"value":"1479-6694","type":"print"},{"value":"1744-8301","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,3]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-03-31","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-11","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-11","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}